Stockholders' Equity (Tables)
|
9 Months Ended |
Oct. 31, 2024 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Stock Options Activity |
Option activity under the Company’s combined stock plans is set forth below (in thousands, except years and per share data): | | | | | | | | | | | | | | | | | | | | | | | | | Number of Shares | | Weighted- Average Exercise Price | | Weighted-
Average
Remaining
Contractual Term
(in years) | | Aggregate Intrinsic Value | | Balances at January 31, 2024 | 9,788 | | | $ | 3.09 | | | 4.2 | | $ | 140,292 | | | Options granted | — | | | — | | | | | | | Options exercised | (1,412) | | | 2.75 | | | | | | | Options cancelled | (1) | | | 7.49 | | | | | | | Balances at October 31, 2024 | 8,375 | | | $ | 3.14 | | | 3.5 | | $ | 73,676 | | | Vested and exercisable at October 31, 2024 | 8,212 | | | $ | 3.16 | | | 3.5 | | $ | 72,099 | | | Vested and expected to vest at October 31, 2024 | 8,375 | | | $ | 3.14 | | | 3.5 | | $ | 73,676 | |
|
| Schedule of Total Intrinsic Value of Options |
The total intrinsic value of options exercised during the periods presented was as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended October 31, | | Nine Months Ended October 31, | | 2024 | | 2023 | | 2024 | | 2023 | | Aggregate intrinsic value of options exercised (in thousands) | $ | 7,106 | | | $ | 4,583 | | | $ | 14,902 | | | $ | 30,876 | |
|
| Schedule of RSU Activity |
The Company’s RSU activity is set forth below (in thousands, except per share data): | | | | | | | | | | | | | | | | | | | Number of Shares | | Weighted- Average Grant Date Fair Value | | Aggregate Intrinsic Value | | Unvested RSUs at January 31, 2024 | 17,190 | | | $ | 23.04 | | | $ | 299,450 | | | RSUs granted | 16,040 | | | 14.79 | | | | | RSUs vested | (7,142) | | | 22.20 | | | | | RSUs cancelled/forfeited | (3,217) | | | 20.06 | | | | | Unvested RSUs at October 31, 2024 | 22,871 | | | $ | 17.94 | | | $ | 273,080 | | | RSUs vested, not yet released at October 31, 2024 | 696 | | | $ | 32.53 | | | |
|
| Schedule of Stock-Based Compensation Expense |
Stock-based compensation expense for stock-based awards to employees and non-employees in the Company’s condensed consolidated statements of operations for the periods below were as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended October 31, | | Nine Months Ended October 31, | | 2024 | | 2023 | | 2024 | | 2023 | | Cost of revenues | $ | 354 | | | $ | 413 | | | $ | 1,030 | | | $ | 1,177 | | | Research and development | 28,087 | | | 29,384 | | | 88,872 | | | 83,928 | | | Sales and marketing | 15,837 | | | 15,584 | | | 48,334 | | | 43,438 | | | General and administrative | 7,677 | | | 7,485 | | | 22,466 | | | 22,026 | | | Total stock-based compensation expense | $ | 51,955 | | | $ | 52,866 | | | $ | 160,702 | | | $ | 150,569 | |
|
| Schedule of Unrecognized Stock-Based Compensation Expense Related to Unvested Awards |
Total unrecognized stock-based compensation expense related to unvested awards not yet recognized under all equity compensation plans was as follows: | | | | | | | | | | | | | October 31, 2024 | | Unrecognized Expense
(in thousands) | | Weighted-Average Expected Recognition Period
(in years) | | Stock options | $ | 188 | | | 3.3 | | RSUs | 376,398 | | | 3.0 | | Total unrecognized stock-based compensation expense | $ | 376,586 | | | 3.0 |
|
| Schedule of Stock Repurchase Activity |
The following table summarizes the stock repurchase activity under the Company’s stock repurchase program (in thousands, except per share data): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended October 31, | | Nine Months Ended October 31, | | 2024 | | 2023 | | 2024 | | 2023 | | Number of shares repurchased | 4,494 | | | — | | | 5,940 | | | — | | Weighted-average price per share | $ | 12.23 | | | $ | — | | | $ | 12.57 | | | $ | — | | Aggregate purchase price | $ | 54,969 | | | $ | — | | | $ | 74,690 | | | $ | — | |
|